Key result
Resting myocardial radiotracer uptake showed no statistically significant correlation with the degree of cardiac fibrosis, vascular density, or inflammation in patients with advanced heart failure.
Why the study?
Advanced regeneration and revascularization strategies are being used to potentially restore myocardial function in advanced heart disease, but predictors of myocardial recovery have not been established.
Does nuclear myocardial perfusion imaging predict vascular or myocardial architecture in patients with advanced heart failure?
Cross-Sectional (n=27)
Blinded to subject and etiology
No
Does nuclear myocardial perfusion imaging predict vascular or myocardial architecture in patients with advanced heart failure?
Nuclear myocardial perfusion imaging poorly predicts the degree of fibrosis or vascular density in advanced heart failure, suggesting it may not reliably identify viable myocardium for novel revascularization therapies.
Answers are grounded in this paper and cite their sources.
Nuclear perfusion imaging may not reflect histology in advanced HF; leaves open its utility for guiding revascularization.
Objectives To determine predictors of tissue that would benefit from improved blood flow in subjects with advanced heart disease. Background Advanced regeneration and percutaneous revascularization strategies including revascularization of chronic total occlusions (CTO) are being used to potentially restore myocardial function in the growing population of patients with advanced heart disease. Predictors of myocardial recovery in this population have not been established. Methods Cardiac tissue was collected from 27 subjects undergoing LVAD or cardiac transplantation who had nuclear perfusion imaging prior to procedure. Histologic analysis for fibrosis, vascular density and inflammation was performed and correlated with nuclear perfusion images from the same areas. In a subset of subjects, correlations of nuclear perfusion with TIMI flow by coronary arteriography was also performed. Results Areas of both normal and abnormal epicardial coronary blood flow had a large variation in radiotracer uptake. There were no statistically significant correlations between uptake of radiotracer at rest and degree of cardiac fibrosis, vascular density or inflammation and the matched area of myocardium. Fibrosis varied from 5-50% in areas with severe defects and areas of normal radiotracer uptake. Endothelial density correlated with inflammation in end-stage heart disease. Conclusions Radiotracer uptake poorly predicted both areas of severe fibrosis that will not benefit from increased blood flow and areas of minimal fibrosis that may recover. Correlation of inflammation and endothelial density support a hypothesis that inflammatory cytokines augment vascularity in myocardium. Novel strategies to improve function in advanced heart disease are in need of better markers of recovery.
No takes yet. Share an insight, caveat, or question.
Farris et al. (2020) conducted a cross-sectional in Advanced heart failure (n=27). Nuclear myocardial perfusion imaging vs. Histologic analysis was evaluated on Correlation between resting radiotracer uptake and degree of cardiac fibrosis, vascular density, or inflammation (p=0.5). Resting myocardial radiotracer uptake showed no statistically significant correlation with the degree of cardiac fibrosis, vascular density, or inflammation in patients with advanced heart failure.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: